Palbociclib in Participants with Pancreatic Cancer and . . . - TAPUR • The TAPUR Study is a phase II multi-basket study designed to identify signals of anti-tumor activity of commercially available targeted agents used in patients (Pts) with advanced cancers that harbor genomic alterations known to be drug targets • In this report, data for two cohorts of Pts with 1) pancreatic and
APPROVAL NOTICE - TAPUR This study is known as the Targeted Agent and Profiling Utilization Registry (TAPUR) Study The TAPUR Study is a precision medicine study testing if off-label treatments work for different types of cancers The study doctor uses gene alterations to match participants to treatment groups
Sign In | TAPUR Skip to main content Contact Us; Sign In; TAPUR
New TAPUR Private Website User Information Request Form Complete this form to request access to the TAPUR Study Private Website Submit the completed form to your ASCO TAPUR Study Liaison Within 3 business days of form submission, you will receive a notification email detailing website access A separate form must be submitted for each individual requiring access to the private website 1
PATIENT ENROLLMENT FOLDER - DRUG MATCHING - TAPUR TAPUR protocol-specified drug-variant matches outlined in Protocol Table 7-1 • The Rules Engine can either be run in Complete View or Portrait View • If the “ Move to next task after Save ” check box is marked after running the Rules Engine, you can view the results by clicking on the Rules Engine form on the left sided navigation pane
Study Site Research Staff Certification Checklist - tapur. org Instructions: This checklist is a tool for recording the required steps for initiating staff members to conduct TAPUR Study activities Complete this checklist at the clinical site to serve as local documentation that the necessary training
TAPUR %PDF-1 6 %âãÏÓ 1795 0 obj > endobj 1815 0 obj > Encrypt 1796 0 R Filter FlateDecode ID[4F2834F3FF55E943ACFBC79318B08525>] Index[1795 285] Info 1794 0 R Length 122
Protocol Quiz - TAPUR TAPUR allows for patients with new or progressive brain metastases to enroll if they meet all other eligibility criteria Please select the exclusion criteria related to new or progressive brain metastases Check all that apply
TAPUR Study Enrollment Report TAPUR Study Enrollment Report Thursday, December 22, 2016 Clinical Site Name Number of participants registered Number of participants in screening process Number of participants that did not enroll Number of participants enrolled Total 224 41 54 129 Michigan Cancer Research Consortium (MCRC) 42 7 10 : 25